Genor Biopharma Revenue and Competitors

Shanghai,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Genor Biopharma's estimated annual revenue is currently $12.7M per year.(i)
  • Genor Biopharma's estimated revenue per employee is $155,000

Employee Data

  • Genor Biopharma has 82 Employees.(i)
  • Genor Biopharma grew their employee count by -2% last year.

Genor Biopharma's People

NameTitleEmail/Phone
1
Senior Director-Head Clinical OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Genor Biopharma?

Genor Biopharma Co. Ltd is a biopharmaceutical powerhouse focusing on developing and commercializing oncology and autoimmune drugs. We have successfully developed drug candidates targeting pathways with blockbuster potentials, encompassing top three oncology targets and five out of the ten bestselling drugs globally. We have leveraged primarily in-house capabilities in establishing a pipeline of 15 targeted drug candidates with tremendous commercialization potentials in China that cover both proven and novel biological pathways.

keywords:N/A

N/A

Total Funding

82

Number of Employees

$12.7M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Genor Biopharma News

2022-04-17 - Still's Disease Treatment Market Size, Outlook And Forecast ...

Biocon Limited, Epirus Biopharmaceuticals, Genor BioPharma Co. Ltd., Hetero Drugs Limited, Mabion SA, Mycenax Biotech Inc., Oncobiologics, Oncodesign SA,...

2022-04-17 - HER2 negative Breast Cancer Pipeline Insights | Research Report 2022 by DelveInsight

... Boehringer Ingelheim, CytomX Therapeutics, Beta Pharma (Suzhou) Co., ... Inc., Kind Pharmaceuticals LLC, Genor Biopharma Co., Ltd.,...

2022-04-17 - Herceptin Biosimilar Market Size, Outlook And Forecast ...

Amgen, AryoGen Biopharma, Biocon, Celltrion, Gedeon Richter, Genor Biopharma, Mabion, Mylan, Roche, The Instituto Vital Brazil.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12M836%N/A
#2
$12.2M84-1%N/A
#3
$12.2M846%N/A
#4
$9.2M88N/AN/A
#5
$18.3M916%N/A